Deuk Spine Institute said on October 27, 2026, that it has performed more than 1,000 Deuk Plasma Rhizotomy procedures over six years and reported pain reductions among patients treated for joint-related pain. The institute did not provide details of how it measured the outcomes.

Key Takeaways

  • The institute reported a complication rate of less than 0.01% but did not describe how the rate was calculated.
  • A third U.S. patent covering the technology was issued on July 21, 2026.

Deuk Plasma Rhizotomy outcomes

The Melbourne, Florida, institute said its outcome data showed 99% elimination of back and neck pain originating in facet and sacroiliac joints, and 85% elimination of knee, hip and shoulder pain. Those figures describe the institute’s reported reduction in pain, not the percentage of patients who became pain-free.

The announcement did not explain the study design, follow-up period or method used to measure the reported outcomes. It also said no narcotic painkillers were prescribed after the procedures.

Procedure and patent

The outpatient procedure uses imaging to guide a probe to nerves around an affected joint, according to the institute. It said a typical procedure takes about 20 minutes and is performed by neurosurgeon Ara Deukmedjian, who invented it and co-founded the institute.

The institute said the latest patent covers an instrument used in the procedure; two earlier patents cover methods. A patent protects an invention but does not establish a treatment’s clinical effectiveness.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.